EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 197 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,468,259 | -49.4% | 471,872 | -28.7% | 0.02% | -52.9% |
Q1 2023 | $6,855,958 | +19.0% | 661,772 | +35.6% | 0.03% | +6.2% |
Q4 2022 | $5,761,875 | -6.1% | 487,881 | +66.9% | 0.03% | -3.0% |
Q3 2022 | $6,135,000 | -39.3% | 292,277 | -10.2% | 0.03% | -36.5% |
Q2 2022 | $10,104,000 | -16.0% | 325,508 | +11.1% | 0.05% | -23.5% |
Q1 2022 | $12,030,000 | +44.9% | 292,987 | +53.4% | 0.07% | +51.1% |
Q4 2021 | $8,300,000 | -12.4% | 190,941 | +0.9% | 0.04% | -26.2% |
Q3 2021 | $9,474,000 | -23.7% | 189,213 | -4.0% | 0.06% | -29.1% |
Q2 2021 | $12,411,000 | +36.9% | 197,027 | +124.5% | 0.09% | +14.7% |
Q3 2020 | $9,067,000 | +2330.8% | 87,748 | +1762.2% | 0.08% | +1775.0% |
Q2 2020 | $373,000 | -39.1% | 4,712 | -55.5% | 0.00% | -77.8% |
Q1 2020 | $612,000 | +70.9% | 10,583 | +59.7% | 0.02% | +157.1% |
Q4 2019 | $358,000 | -79.4% | 6,628 | -80.1% | 0.01% | -76.7% |
Q3 2019 | $1,742,000 | +127.4% | 33,324 | +110.0% | 0.03% | +42.9% |
Q2 2019 | $766,000 | – | 15,866 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |